Surfactant treatment for newborn breathing distress
Part of Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial looks at giving a “surfactant” medicine (a substance that helps keep baby lungs open) to newborns who have serious breathing problems soon after birth. It may help babies with neonatal respiratory distress or acute breathing distress, especially if they’re treated in the early time window.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born before 37 weeks (preterm) and admitted to the NICU within 24 hours after birth
- Your baby has been diagnosed with either NRDS or NARDS (serious newborn breathing trouble)
- Your baby has received at least one dose of surfactant
- Your baby does not have major birth defects (major congenital anomalies)
- Your baby does not have a chromosome problem (chromosomal abnormality)
- Your baby does not have a problem in the upper airways that explains the breathing trouble (upper respiratory tract abnormality)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a less invasive way to give surfactant (a lung treatment) to babies born a few weeks early who need breathing help. It aims to see if this method works as well as standard care.
This study tests a new medicine called APC-0101, a type of surfactant, for premature babies with breathing problems (respiratory distress syndrome). It may help their lungs work better and reduce the need for more breathing support.
This trial compares a new method of giving surfactant (a substance that helps babies' lungs work better) to preterm infants who have breathing problems. The goal is to see if giving surfactant through a thin tube without a breathing tube works as well as the usual method.
This trial uses bedside ultrasound to see how well the lungs and blood flow are working in premature babies who receive surfactant, a medicine that helps their lungs open up.
This trial tests whether giving surfactant (a substance that helps lungs stay open) to premature babies with Respiratory Distress Syndrome (RDS) through a mask on the throat (supraglottic airway) is safe and effective. It may be an option for babies who need extra oxygen but are not on a breathing tube.
This study looks at different ways doctors give a life-saving medication called surfactant to premature babies who are struggling to breathe. Researchers want to understand which delivery methods work best and help improve care.
Hear when a new Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.